Castera L, Friedrich-Rust M, Loomba R,et al. Noninvasive assessment of liver disease in patients with nonalcoholic fatty Liver disease[J].Gastroenterology, 2019, 156: 1264-1281, e4.
[3]
Schwimmer J, Ugalde-Nicalo P, Welsh J, et al. Effect of a low free sugar diet vs usual diet on nonalcoholic fatty liver disease in adolescent boys: a randomized clinical trial[J].JAMA, 2019, 321(3): 256-265.
[4]
Bellentani S, Scaglioni F, Marino M, et al. Epidemiology of Non-Alcoholic fatty liver disease[J]. Digest Dis, 2010, 28(1):155-161.
Day C P, James O F. Steatohepatitis: a tale of two "hits"[J]. Gastroenterology, 1998,114(4):842.
[7]
Feldstein A E. Novel insights into the pathophysiology of nonalcoholic fatty liver disease[J]. Semin Liver Dis, 2010,30(4):391.
[8]
Georgoulis M, Fragopoulou E, Kontogianni M D, et al. Blood redox status is associated with the likelihood of nonalcoholic fatty liver disease irrespectively of diet’s total antioxidant capacity[J]. Nutr Res, 2015,35(1):41-48.
Moschen A R, Tilg H. Nutrition in pathophysiology and treatment of nonalcoholic fatty liver disease[J]. Current Opinion in Clinical Nutrition and Metabolic Care, 2008, 11(5):620-625.
[11]
Rahman V J. Low-fat vs low-carbohydrate diets and weight loss.[J]. JAMA, 2018, 320(2):202-204.
[12]
Ohashi T, Kato M, Yamasaki A, et al. Effects of high fructose intake on liver injury progression in high fat diet induced fatty liver disease in ovariectomized female mice[J]. Food & Chemical Toxicology, 2018, 118:190-197.
Kargulewicz A, Stankowiak-Kulpa H, Marian G. Dietary recommendations for patients with nonalcoholic fatty liver disease[J]. Gastroenterology Review, 2014, 9(1):18-23.
[15]
Kwok R, Choi K C, Wong L H, et al. Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study[J]. Gut, 2016,65(8):1359-1563.
[16]
Westerbacka J, Lammi K, HKkinen A M, et al. Dietary fat content modifies liver fat in overweight nondiabetic Subjects[J]. J Clin Endocrinol & Metab, 2005, 90(5):2804-2809.
[17]
Ratziu V, Ghabril M, Romero M, et al. Recommendations for management and treatment of nonalcoholic steatohepatitis[J]. Transplantation, 2019, 103(1):28-42.
[18]
Association A D, Bantle J P, Wylierosett J, et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association[J]. Diabetes Care, 2007, 30(4):S48.
[19]
European Association for Cardiovascular Prevention & Rehabilitation.‘Ten Commandments’from the 2016 ESC/EAS Guidelines for the management of dyslipidaemias[J]. Eur Heart J, 2011, 37(39):2966.1-2966.
[20]
Marchesi J R, Adams D H, Fava F, et al. The gut microbiota and host health: a new clinical frontier[J]. Gut, 2016, 65(2):330-339.
[21]
Imajo K, Yoneda M, Ogawa Y, et al. Microbiota and nonalcoholic steatohepatitis[J]. Seminars in Immunopathol, 2014, 36(1):115-132.
[22]
Mahady S E, Wong G, Craig J C, et al. Pioglitazone and vitamin E for nonalcoholic steatohepatitis: A cost utility analysis[J]. Hepatology, 2012, 56(6):2172-2179.
[23]
Chalasani N, Younossi Z, Lavine J E, et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association[J]. Hepatology, 2012, 55(6):2005-2023.
[24]
Seitz H K, Mueller S, Hellerbrand C, et al. Effect of chronic alcohol consumption on the development and progression of non-alcoholic fatty liver disease (NAFLD)[J]. Hepatobiliary Surgery & Nutrition, 2015, 4(3):147-151.
Dubé J J, Amati F, Stefanovic-Racic M, et al. Exercise-induced alterations in intramyocellular lipids and insulin resistance: the athlete’s paradox revisited[J]. Am J Physiol Endocrinol Metab, 2008,294(5):E882
[27]
Linden M A, Sheldon R D, Meers G M, et al. Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis[J]. J Physiology, 2016, 594(18):5271-5277.
[28]
Oh S, Tanaka K, Warabi E. Exercise reduces inflammation and oxidative stress in obesity-related liver diseases[J]. Med Sci Sports Exerc, 2013,45(12):2214-2218.
[29]
Kowdley K V, Belt P, Wilson L A, et al. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease[J]. Hepatology, 2012, 55(1):77-85.
2019, Vol. 30 
